Table 5.
Parameter | Patients | Control | P-value |
---|---|---|---|
Non-Parametric | Median (Q1-Q3) | Median (Q1-Q3) | |
Complement C3 | 192.5 (181–204) | 134 (88–183) | 0.083 |
Complement C4-B | 103 (96–110) | 38 (23–60) | 0.000 |
C4b-binding protein alpha chain | 18.5 (18–19) | 15 (10.25–19.75) | 0.192 |
Complement C1r subcomponent | 15.5 (12–19) | 16.5 (6.75–24.25) | 0.895 |
Complement C1s subcomponent | 9 (5–13) | 6 (4–11.75) | 0.311 |
Complement C5 | 11 (9–13) | 4 (2–8) | 0.620 |
Complement C1q subcomponent subunit B | 3.5 (3–4) | 5 (3–7) | 0.142 |
Complement component C9 | 23 (21–25) | 11 (7–18) | 0.000 |
Complement factor B | 11.5 (8–15) | 5 (3–9.75) | 0.025 |
Complement factor H | 12.5 (5–20) | 5 (2–10) | 0.150 |
Complement C1q subcomponent subunit A | 2 (1–4) | 3 (2–5) | 0.315 |
Complement C1q subcomponent subunit C | 4 (2–6) | 2 (1–3) | 0.035 |
Complement component C7 | 6 (4–8) | 2 (1.75–4) | 0.061 |
Parametric | Mean ± SD | Mean ± SD | |
Complement component C6 | 4.27 ± 0.43 | 1.33 ± 0.52 | 0.000 |
A p-value of < 0.05 was deemed to be statistically significant